Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Immetas Logo
Immetas CB Rank
1238056
Heat Score
31
Immetas is a developer of novel therapeutic solutions for treating cancers and inflammatory diseases.
Founded
obfuscation
Private East Hanover, New Jersey, United States immetas.com
Bioinformatics
Biotechnology
Health Care
Overview

Immetas
Heat Score
31

Growth Score
pts
in past quarter
Heat Score 31
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Immetas

CB Rank
1238056
Immetas is a developer of novel therapeutic solutions for treating cancers and inflammatory diseases.
Founded
obfuscation
Private East Hanover, New Jersey, United States immetas.com
Bioinformatics
Biotechnology
Health Care

Key People

Details

Also Known As Immetas Therapeutics
Operating Status Active
Company Type For Profit
Founders  David Sinclair, J. Gene Wang
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Lead Drug Development Programs
Focused on age-related cancers and osteoarthritis, these programs aim to modulate inflammation in the tumor microenvironment and synovial inflammation in osteoarthritis.
BiSpecific (BiSAb) Formats
A platform for generating bispecific antibodies with two binding sites for each antigen, used to regulate inflammation in the tumor microenvironment.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Employee Profiles 2

Employee Profiles

News
Technology
View Tech Report

IT Spend

$99.8KThis year, Immetas is projected to spend $99.8K on IT, according to Aberdeen.

Active Website Tech Count

3Immetas is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, Euro, and  CommonCrawl Top 100m.

Total IP

3The intellectual property of Immetas includes 3 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Immetas's headquarters? Immetas is located in East Hanover, New Jersey, United States.Who are Immetas's competitors? Alternatives and possible competitors to Immetas may include Roche, Takeda, and  Boehringer Ingelheim.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|